Skip to content

electroCore, Inc. ECOR Sale of stock, price per share (in dollars per share)

Sale of stock, price per share (in dollars per share) at other companies

Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$0.01
electroCore, Inc. logo
electroCore, Inc.ECOR
$6.62
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$60.00
CBAK Energy Technology, Inc. logo
CBAK Energy Technology, Inc.CBAT
$5.18
New America Acquisition I
 logo
New America Acquisition I NWAX
$10.00
CEP
Cantor Equity Partners IV, Inc. Class A Ordinary SharesCEPF
$10.00

Other financials

Income statement

See full
Revenue$9.6M+42.6%
Gross profit$8.4M+46.6%
Operating income-$5.3M-39.1%
Net income-$5.3M-36.7%
EPS (diluted)-$0.59-25.5%

Balance sheet

See full
Cash & equivalents$4.9M+20.5%
Total debt$9.5M+127%
Total equity-$5.7M-230%
Total assets$15.5M-3.5%

Cash flow

See full
Operating cash flow-$3.0M+30.9%
CapEx$2.0K-94.6%
Free cash flow-$3.0M+31.5%

Valuation

See full
Market cap$71.67M+78.9%
Enterprise value$76.31M+87.6%
P/S2.1×+0.6×

Profitability

See full
Gross margin87.2%+2.0pp
Operating margin-42%-3.3pp
Net margin-44.1%-2.0pp
FCF margin-19.7%

Returns & leverage

See full
Return on equity-210.6%+125pp
Debt / equity3.8×+3.5×
Current ratio-0.5×

Where this comes from

Reported directly by electroCore, Inc. in its filing.

Tagged under the XBRL concept us-gaap:SaleOfStockPricePerShare.

The official record: electroCore, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about electroCore, Inc.'s sale of stock, price per share (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is electroCore, Inc.'s sale of stock, price per share (in dollars per share)?
electroCore, Inc. (ECOR) reported sale of stock, price per share (in dollars per share) of $6.62 in Q1 2026.
What does sale of stock, price per share (in dollars per share) mean?
This metric tracks the average price per share at which the company has issued or sold its common stock during a specific period. It provides a benchmark for the market's valuation of the company's equity during capital-raising activities.